Abstract: Provided is a semiconductor doped with an increased binding energy hydrogen species and a method of making the doped semiconductor.

Abstract: A power source and hydride reactor is provided comprising a reaction cell for the catalysis of atomic hydrogen to form novel hydrogen species and compositions of matter comprising new forms of hydrogen, a source of atomic hydrogen, a source of a hydrogen catalyst comprising a reaction mixture of at least one reactant comprising the element or elements that form the catalyst and at least one other element, whereby the catalyst is formed from the source and the catalysis of atomic hydrogen releases energy in an amount greater than about 300 kJ per mole of hydrogen during the catalysis of the hydrogen atom. Further provided is a reactor wherein the reaction mixture comprises a catalyst or a source of catalyst and atomic hydrogen or a source of atomic hydrogen (H) wherein at least one of the catalyst and atomic hydrogen is released by a chemical reaction of at least one species of the reaction mixture or between two or more reaction-mixture species.

Abstract: This invention relates to a highly stable silicon hydride (SiH(1/p)) surface coating formed from high binding energy hydride ions. SiH(1/p) may be synthesized in a cell for the catalysis of atomic hydrogen to form novel hydrogen species and/or compositions of matter containing new forms of hydrogen. The reaction may be maintained by a microwave plasma of a source of atomic hydrogen, a source of catalyst, and a source of silicon.

Abstract: Provided is a laser based on the formation of an inverted population in an atom or ion of an element wherein at least one oxidation state of the element serves as a catalyst with atomic hydrogen to form states that are lower in energy than that of the n=1 state of having a binding energy of 13.6 eV. The catalytic reaction between atomic hydrogen and the catalyst pumps the exited states of catalyst or species caused by the ionization of the catalyst as the reaction releases energy with the formation of atomic-hydrogen states with binding energies lower than those of uncatalyzed atomic hydrogen. In an embodiment, the system comprises a source of catalyst and hydrogen gases and a means to cause a plasma of these gases. The plasma dissociates molecular hydrogen to atomic hydrogen and ionizes the source of catalyst to form the catalyst. The catalyst looses one or more electrons during the catalytic reaction, and the recombination of electrons with the ionized catalyst creates an inverted population.

Abstract: Provided are apparatus and methods for forming a multidimensional image of inanimate or animate objects which utilize a magnetization source (112) to magnetize a volume of an object to be imaged, a radiation source (118) for applying a radiation field to the object to be imaged, an output signal detector (120) for producing output signals in response to the secondary radiation at a plurality of spatial locations outside of the object as a function of time, processors (126, 126a and 126b) for determining a plurality of Fourier components, for associating the Fourier components due to each voxel (14) by phase, and for converting each set of components into a voxel location, and an image processor (128) for producing an image.

Abstract: Provided is a system of computing and rendering a nature of a chemical bond based on physical, Maxwellian solutions of charge, mass, and current density functions of hydrogen-type molecules and molecular ions. The system includes a processor for processing Maxwellian equations representing charge, mass, and current density functions of hydrogen-type molecules and molecular ions and an output device in communication with the processor for displaying the nature of the chemical bond.

Abstract: Prodrug compounds capable of permeating a desired biological compartment and releasing a biologically active molecule in active form to effect a therapeutic functional change in the compartment to which it is introduced.

Abstract: Provided is an inverted population of hydrogen, formed from a novel catalytic reaction of hydrogen atoms to form lower-energy hydrogen. The inverted population of hydrogen is capable of lasing. The power may be utilized as laser light or the light due to stimulated or spontaneous emission may be converted to electricity with a photon-to-electric converter such as a photovoltaic cell.

Abstract: Provided is a power source and/or power converter. The power source includes a cell 910 for the catalysis of atomic hydrogen to form novel hydrogen species and/or compositions of matter comprising new forms of hydrogen. The reaction can be initiated and/or maintained by a microwave or glow discharge plasma of hydrogen and a source of catalyst The plasma power may be converted to electricity by a magnetohydrodynamic power converter 913 or a plasmadynamic power converter.

Abstract: This invention relates to technologies, including Direct E×B, Magnetohydrodynamic, and Plasmadynamic, for the conversion of plasma energy into electrical energy.

Abstract: Provided are apparatus and methods for forming a multidimensional image of inanimate or animate objects which utilize a magnetization source (112) to magnetize a volume of an object to be imaged, a radiation source (118) for applying a radiation field to the object to be imaged, an output signal detector (120) for producing output signals in response to the secondary radiation at a plurality of spatial locations outside of the object as a function of time, processors (126, 126a and 126b) for determining a plurality of Fourier components, for associating the Fourier components due to each voxel (14) by phase, and for converting each set of components into a voxel location, and an image processor (128) for producing an image.

Abstract: Prodrug compounds capable of permeating a desired biological compartment and releasing a biologically active molecule in active form to effect a therapeutic functional change in the compartment to which it is introduced.

Abstract: This invention relates to a highly stable silicon hydride (SiH(1/p)) surface coating formed from high binding energy hydride ions. SiH(1/p) may be synthesized in a cell for the catalysis of atomic hydrogen to form novel hydrogen species and/or compositions of matter containing new forms of hydrogen. The reaction may be maintained by a microwave plasma of a source of atomic hydrogen, a source of catalyst, and a source of silicon.

Abstract: A three-dimensional magnetic susceptibility map of an object including a patient placed in a magnetic field is generated from a three-dimensional map of the resonant radio frequency (RF) magnetic flux external to the patient. The magnetic susceptibility of each voxel is determined from the shift of the Larmor frequency due to the presence of the voxel in the magnetizing field. The intensity variation of the transverse RF field over space is used to determine the coordinate location of each voxel. The RF field is the near field which is a dipole that serves as a basis element to form a unique reconstruction. The geometric system function corresponding to a dipole which determines the spatial intensity variations of the RF field is a band-pass for k&rgr;=kz. In the limit, each volume element is reconstructed independently in parallel with all other volume elements such that the scan time is no greater than the nuclear free induction decay (FID) time.

Abstract: A method and means to produce an antigravitational force for propulsion and/or levitation comprise a source of fundamental particles including electrons and a means to give the fundamental particles negative curvature; whereas, the gravitating body is comprised of matter of positive curvature where opposite curvatures provide a mutually repulsive antigravitational force. Electrons are given negative curvature by elastically scattering electrons of an electron beam from atoms such that negatively curved electrons (pseudoelectrons) emerge. The emerging beam of negatively curved electrons experience an antigravitational force, and (on the Earth) the beam moves upward (away from the Earth). To use this invention for propulsion or levitation, the antigravitational force of the electron beam is transferred to a negatively charged plate. The Coulombic repulsion between the beam of electrons and the negatively charged plate causes the plate (and anything connected to the plate) to lift.

Abstract: Pharmaceuticals and Apparatus used in combination for diagnosis and tissue necrosis applicable to provide effective and selective therapy using the Mossbauer absorption phenomenon. Selected pharmaceutical compounds containing a radiation absorber isotope are administered to a tissue and excited by a radiation source which provides energy at the corresponding resonant Mossbauer absorption frequency of isotope containing pharmaceutical, where excitation effects nuclear transitions to cause highly selective energy absorption in the selected target tissue. For diagnostic purposes, de-excitation fluorescence of the isotope is monitored. For therapeutic purposes, the energy is converted to particle radiation by the isotope at the target tissue by internal conversion followed by an Auger electron cascade which results in radiolysis of DNA resulting in lethal double strand breaks in the DNA molecules of the target tissue.

Abstract: Pharmaceuticals and Apparatus used in combination for diagnosis and tissue necrosis applicable to provide effective and selective therapy using the Mossbauer absorption phenomenon. Selected pharmaceutical compounds containing a radiation absorber isotope are administered to a tissue and excited by a radiation source which provides energy at the corresponding resonant Mossbauer absorption frequency of isotope containing pharmaceutical, where excitation effects nuclear transitions to cause highly selective energy absorption in the selected target tissue. For diagnostic purposes, de-excitation fluorescence of the isotope is monitored. For therapeutic purposes, the energy is converted to particle radiation by the isotope at the target tissue by internal conversion followed by an Auger electron cascade which results in radiolysis of DNA resulting in lethal double strand breaks in the DNA molecules of the target tissue.

Abstract: Methods and apparatus for releasing energy from hydrogen atoms (molecules) by stimulating their electrons to relax to quantized lower energy levels and smaller radii (smaller semimajor and semiminor axes) than the "ground state" by providing energy sinks or means to remove energy resonant with the hydrogen energy released to stimulate these transitions. An energy sink, energy hole, can be provided by the transfer of at least one electron between participating species including atoms, ions, molecules, and ionic and molecular compounds. In one embodiment, the energy hole comprises the transfer of t electrons from one or more donating species to one or more accepting species whereby the sum of the ionization energies and/or electron affinities of the electron donating species minus the sum of the ionization energies and/or electron affinities of the electron accepting species equals approximately mX27.21 eV (mX48.6 eV) for atomic (molecular) hydrogen below "ground state" transitions where m and t are integers.

Abstract: A broad class of pharmaceutical agents which react directly with electron carriers or with reactive species produced by electron transport to release a pharmacologically active molecule to effect a therapeutic functional change in the organism by a receptor or nonrecepter mediated action.

Abstract: The DNA sequencing apparatus contains the following components. A first reaction vessel contains a reaction chamber into and out of which can be transferred reagents, reactants and reaction products. A device for separating individual oligonucleotides and polynucleotides on the basis of length, such as an electrophoretic unit, receives reaction products from the first reaction vessel. A second reaction vessel is designed for oxidizing pentose sugars. It comprises a reaction chamber having a device for transferring reactants and reagents into the reaction chamber and gaseous by-products of a reaction out of the reaction chamber. Separated oligonucleotides and polynucleotides can be selectably transferred from the separating device alternatively into the first or the second reaction vessel. The device also includes a second transfer device for transferring the gaseous by-products out of the second reaction vessel and a collection chamber for collecting the gaseous by-products.